1. Home
  2. NAGE vs SUPV Comparison

NAGE vs SUPV Comparison

Compare NAGE & SUPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAGE
  • SUPV
  • Stock Information
  • Founded
  • NAGE 1999
  • SUPV 1887
  • Country
  • NAGE United States
  • SUPV Argentina
  • Employees
  • NAGE N/A
  • SUPV N/A
  • Industry
  • NAGE Medicinal Chemicals and Botanical Products
  • SUPV Commercial Banks
  • Sector
  • NAGE Health Care
  • SUPV Finance
  • Exchange
  • NAGE Nasdaq
  • SUPV Nasdaq
  • Market Cap
  • NAGE 861.0M
  • SUPV 905.2M
  • IPO Year
  • NAGE N/A
  • SUPV 2016
  • Fundamental
  • Price
  • NAGE $9.98
  • SUPV $9.08
  • Analyst Decision
  • NAGE Strong Buy
  • SUPV Buy
  • Analyst Count
  • NAGE 3
  • SUPV 2
  • Target Price
  • NAGE $17.00
  • SUPV $17.00
  • AVG Volume (30 Days)
  • NAGE 1.2M
  • SUPV 1.4M
  • Earning Date
  • NAGE 08-06-2025
  • SUPV 08-13-2025
  • Dividend Yield
  • NAGE N/A
  • SUPV 2.06%
  • EPS Growth
  • NAGE N/A
  • SUPV N/A
  • EPS
  • NAGE 0.22
  • SUPV 0.09
  • Revenue
  • NAGE $116,303,000.00
  • SUPV $631,132,570.00
  • Revenue This Year
  • NAGE $26.44
  • SUPV $30.41
  • Revenue Next Year
  • NAGE $20.06
  • SUPV $40.48
  • P/E Ratio
  • NAGE $46.46
  • SUPV $20.90
  • Revenue Growth
  • NAGE 35.90
  • SUPV N/A
  • 52 Week Low
  • NAGE $3.10
  • SUPV $6.75
  • 52 Week High
  • NAGE $14.69
  • SUPV $19.75
  • Technical
  • Relative Strength Index (RSI)
  • NAGE 48.56
  • SUPV 36.19
  • Support Level
  • NAGE $9.37
  • SUPV $9.46
  • Resistance Level
  • NAGE $10.45
  • SUPV $10.16
  • Average True Range (ATR)
  • NAGE 0.60
  • SUPV 0.62
  • MACD
  • NAGE 0.11
  • SUPV -0.16
  • Stochastic Oscillator
  • NAGE 43.29
  • SUPV 1.40

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

About SUPV Grupo Supervielle S.A. each Representing five Class B shares

Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, and Asset Management and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.

Share on Social Networks: